Armistice Capital’s Silexion Therapeutics SLXN Stock Holding History
Bought
Maintained
Sold
Other funds holding SLXN
WAM
RMI
BP
PK
Armistice Capital's SLXN Position: Q3 2026 in Review
Armistice Capital opened a new position in Silexion Therapeutics (SLXN) in Q3 2026: 21,875 shares worth $146K. The stake represents ﹤0.01% of the portfolio and ranks #322 among its holdings.
10 funds tracked by Wall St. Rank hold SLXN as of Q3 2026.
- Armistice Capital held 21,875 shares of Silexion Therapeutics worth $146K as of Q3 2026.
- Silexion Therapeutics was a new Armistice Capital position in Q3 2026.
- Silexion Therapeutics made up ﹤0.01% of Armistice Capital's portfolio in Q3 2026, its #322 holding.
- 10 funds tracked by Wall St. Rank held Silexion Therapeutics as of Q3 2026.
Based on Armistice Capital's 13F filing for Q3 2026, filed 16 Nov 2026.